Parvalbumin-expressing interneurons, or PV-INs, play a critical role in regulating brain circuits by providing powerful perisomatic inhibition to principal neurons. This inhibition controls how principal neurons are recruited into active ensembles and manages network states, particularly in hippocampal feedforward circuits where it constrains the integration of excitatory inputs. The learning-related plasticity of these inhibitory neurons supports memory precision, and they remain plastic in adulthood. Experience can induce sustained, reversible changes in the molecular state and connectivity of PV-INs, with activity-dependent signaling pathways coordinating adjustments in excitation and inhibition. These observations suggest that circuit dysfunction in neuropsychiatric disorders may reflect an impaired capacity to recalibrate inhibition as experience changes.
Human genetics has identified numerous genes associated with autism, schizophrenia, and bipolar disorder that are involved in gene regulation and neuronal communication. However, connecting these genes to specific adaptive circuit mechanisms remains difficult, especially for genes with widespread developmental functions. Their association with disease does not reveal whether they also regulate plasticity in mature neurons or whether this regulation is causally involved in disease. Shih and colleagues addressed this challenge by identifying genes recruited in PV-INs when excitatory inputs engage an adult inhibitory circuit. They then tested whether selected candidates could restore circuit and cognitive functions in autism model mice.
The study exploited a defined connection between dentate granule cell mossy fiber terminals and PV-INs in hippocampal CA3/2. Reducing granule cell ABLIM3, a brake on mossy fiber filopodial growth, increases filopodial excitatory contacts onto PV-INs. This manipulation recruits feedforward inhibition in CA3/CA2 and reproduces an established structural correlate of experience without requiring behavioral training. By combining this manipulation with PV-IN-specific purification of ribosome-associated mRNAs, the researchers yielded an input-driven screen for candidate experience-dependent PV-IN plasticity genes.
Remarkably, the upregulated candidate PV-IN plasticity genes include 82 high-confidence autism-associated genes, along with genes implicated in schizophrenia and bipolar disorder. Approximately one-third of these PV-IN plasticity genes encode transcriptional or epigenetic regulators. Many candidates, including Meis2, Bcl11, Tbr1, and Herc1, are associated with disease through loss-of-function variants. Their recruitment during enhanced inhibitory plasticity suggests that reduced gene dosage in neuropsychiatric disorders could limit the ability of PV-INs to match their output to changing excitatory drive, even when inhibitory transmission is not uniformly diminished.
Increasing expression of Meis2, Bcl11a, Tbr1, or Herc1 enhanced perisomatic inhibitory synapse density, providing functional support for the screen. The authors then focused on Meis2 and adult Cntnap2-null autism model mice. Meis2 is a powerful homeobox transcription factor with multiple important roles in brain development. Mutants in the neurexin gene Cntnap2 have fewer PV-IN synapses and fail to show the social experience-dependent increases in Meis2 expression and perisomatic innervation observed in wild-type mice.
Viral Meis2 expression, directed preferentially to PV-INs in CA3/2 by the S5E2 enhancer, restored perisomatic synapse density, interneuron excitability, and feedforward inhibition onto CA2 principal neurons. Meis2 expression also restored the occurrence of inhibitory long-term depression, a mechanism previously implicated in routing information through CA2. Functional recovery therefore encompasses the capacity to modify inhibition, alongside its baseline strength. Tbr1 expression increased inhibitory connectivity without comparably altering intrinsic excitability, suggesting that individual PV-IN plasticity genes might control separable components of the adaptive response.
At the behavioral level, Meis2 expression rescued object-location and social-recognition memory in mutant mice. These improvements were accompanied by more selective reactivation of social-stimulus ensembles in CA2 and recovery of sharp-wave ripple properties recorded in CA1 during post-experience non-rapid eye movement sleep. This links cellular rescue to network processes relevant to social memory. Finally, sustained Meis2 expression reduced later spontaneous seizure frequency, indicating broader functional benefits beyond specific memory tasks.
This study reveals that at least two genes induced upon experience-dependent plasticity in mature PV-INs can restore several levels of function when expressed in adult PV-INs in a genetic mouse model of autism. This occurs despite a persistent developmental genetic lesion. The substantial overlap between PV-IN plasticity genes and genes whose reduced expression is associated with neuropsychiatric diseases makes experience-dependent inhibitory plasticity a plausible point of convergence across genetically heterogeneous disorders.
However, while adult rescue establishes sufficiency for functional compensation, it does not establish that deficient Meis2 signaling for PV-IN plasticity originally caused the Cntnap2-null phenotype. It also does not prove that the same mechanism has a causal role in autism, schizophrenia, or bipolar disorder. Several of the discovered PV-IN plasticity-related genes have multiple important roles in brain development, which might influence the emergence of neuropsychiatric disorders. Temporally controlled loss-of-function experiments might help determine which PV-IN plasticity genes are required for normal adult plasticity and to separate these roles from effects on circuit maturation.
Meis2 is especially informative because its established developmental functions do not imply a role in specifying hippocampal PV-IN identity. Defining its endogenous induction and direct targets in adult PV-INs might reveal whether overexpression reinstates a physiological program or recruits an alternative compensatory state. The different effects of Meis2 and Tbr1 further invite a dissection of how synapse formation, intrinsic excitability, and inhibitory synaptic plasticity contribute individually to recovery. A further potentially important follow-up line of research might probe convergence between distinct genetic models of neuropsychiatric disorders and experience-dependent PV-IN plasticity.
Such experiments might identify shared functional deficits even when baseline circuit abnormalities differ. For translational purposes, the relevant objective might be to recover appropriately timed, experience-sensitive inhibition. Establishing regional specificity and whether benefits persist after expression is withdrawn will be of particular interest. In one intriguing scenario, restored PV-IN plasticity might permit learning to stabilize favorable circuit changes. Regardless of how broadly the mechanism uncovered in this study will be relevant to neuropsychiatric conditions, the findings provide a means to ask which consequences of developmental disruption remain modifiable through the adaptive machinery of adult inhibitory neurons.
The identification of these plasticity genes relied on a specific structural manipulation in the adult mouse hippocampus. By reducing the expression of ABLIM3 in dentate granule cells, the researchers removed a molecular brake on mossy fiber filopodial growth. This intervention increased the number of excitatory contacts made onto PV-INs, effectively mimicking the structural changes associated with experience without the need for behavioral training. This approach allowed the team to isolate the molecular response specifically triggered by enhanced excitatory input. The resulting screen identified a set of genes that are upregulated in PV-INs during this process, providing a direct link between synaptic structural changes and the transcriptional programs that support them.
The overlap between these identified plasticity genes and known disease-associated genes is substantial. The screen revealed 82 high-confidence autism-associated genes, alongside genes implicated in schizophrenia and bipolar disorder. This convergence suggests that the molecular machinery required for normal inhibitory plasticity is frequently disrupted in neuropsychiatric conditions. Many of the candidates, such as Meis2, Bcl11, Tbr1, and Herc1, are associated with disease through loss-of-function variants. This pattern implies that a reduction in the dosage of these genes may limit the ability of PV-INs to adjust their output in response to changing excitatory drive. The findings indicate that the failure to recalibrate inhibition, rather than a uniform loss of inhibitory transmission, may be a key feature of these disorders.
The functional validation of these candidates demonstrated that increasing their expression could restore specific aspects of circuit function. This structural change was accompanied by functional improvements in the circuit. For Meis2, viral expression restored not only the baseline strength of inhibition but also the capacity for inhibitory long-term depression. This form of synaptic plasticity is crucial for routing information through the CA2 region of the hippocampus. The restoration of this dynamic capability suggests that the intervention reinstated the adaptive flexibility of the inhibitory circuit, allowing it to respond appropriately to experience.
The behavioral consequences of this molecular intervention were significant. Mice expressing Meis2 showed rescued object-location and social-recognition memory. These improvements were linked to specific network-level changes, including more selective reactivation of social-stimulus ensembles in CA2. The intervention also reduced the frequency of spontaneous seizures, suggesting broader stabilizing effects on the neural circuit. These results connect the cellular-level rescue of PV-IN plasticity to tangible improvements in cognitive and behavioral outcomes.
Despite these positive findings, the study has important limitations regarding causality. The adult rescue demonstrates that increased expression of these genes is sufficient to compensate for the developmental lesion, but it does not prove that deficient signaling in these genes originally caused the phenotype. The genes identified have multiple roles in brain development, and their effects on adult plasticity may be distinct from their developmental functions. Temporally controlled loss-of-function experiments would be necessary to determine which specific genes are required for normal adult plasticity and to separate these roles from their impact on circuit maturation. The findings highlight a potential point of convergence for genetically heterogeneous disorders, but further research is needed to establish the precise causal mechanisms in human neuropsychiatric conditions.
Subject of Research: Molecular regulators of parvalbumin-expressing interneuron plasticity and their role in restoring cognitive function in autism model mice
Article Title: PV interneuron plasticity for neuropsychiatric disorders
Article References: Caroni, P. (2026). PV interneuron plasticity for neuropsychiatric disorders. Cell Research. https://doi.org/10.1038/s41422-026-01318-5
Image Credits: AI Generated
DOI: 10.1038/s41422-026-01318-5
Keywords: PV interneurons, autism, Meis2, Cntnap2, hippocampus, neuropsychiatric disorders, synaptic plasticity, memory, inhibitory circuits, transcription factors, interneuron, plasticity
Cite Scienmag News
Drew Townsend. (November 16, 2026). Meis2 expression restores memory and circuit function in autism model mice. Scienmag. https://scienmag.com/meis2-expression-restores-memory-and-circuit-function-in-autism-model-mice/
Drew Townsend. "Meis2 expression restores memory and circuit function in autism model mice." Scienmag, 16 November 2026, https://scienmag.com/meis2-expression-restores-memory-and-circuit-function-in-autism-model-mice/. Accessed 16 November 2026.
Drew Townsend. "Meis2 expression restores memory and circuit function in autism model mice." Scienmag. November 16, 2026. https://scienmag.com/meis2-expression-restores-memory-and-circuit-function-in-autism-model-mice/








